Target Audience

This activity was developed for Physicians, Nurse Practitioners, Physician Assistants, and Registered Nurses who work in Family or Internal Medicine.

Goals and Objectives

Upon completion of this activity, participants will demonstrate the ability to:

1. Describe the relationship of daytime sleepiness to obstructive sleep apnea and other sleep disorders.
2. Explain the methods for evaluating excessive sleepiness.
3. Discuss evidence-based pharmacological and non-pharmacological treatment options for daytime sleepiness.
4. List criteria for referring patients with excessive sleepiness to sleep specialists.

Accreditation and Designation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

National Jewish Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

National Jewish Health is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 12724. This program is approved for 1.2 Nursing Contact Hours.

Disclosure Information Listed for CME Content Development and Approval Committee and Participating Program Faculty

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and medical writers in a position to control the content of this activity are expected to disclose any or not significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

Significant financial interest is defined as receiving, or in the past twelve months having received, a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.

All CME Educational Activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty Disclosures

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all persons in a position to control the content of a CME activity, including the CME review committee disclose all significant financial interest with commercial interests.

KEY

Sheila Tsai, MD
National Jewish Health
Department of Medicine
Division of Sleep Medicine
Assistant Professor of Medicine
University of Colorado Denver
Has no significant financial interest to report

John Harrington, MD
Medical Director, Sleep Center
National Jewish Health
Assistant Professor of Medicine
University of Colorado Denver
I - Actelion Pharmaceuticals Ltd.

Frank Verloin deGruy, III, MD, MSFM
Woodward-Chisholm Professor and Chair
Department of Family Medicine
University of Colorado Denver School of Medicine
Has no significant financial interest to report

Robert S. Schwartz, MD
Goodstein Professor of Medicine/Geriatrics
Director, Center on Aging
Head, Division of Geriatrics
Medical Director, Senior's Clinic
University of Colorado Denver
I - Solvay, Takeda

Susan Jorgenson, RN, MSN, AE-C
Pulmonary Clinical Nurse Specialist
National Jewish Health
Faculty, University of Colorado Denver
School of Nursing
Has no significant financial interest to report

Cindy Lampner, MLS
Medical Writer
Has no significant financial interest to report

Harold Nelson, MD
Professor, Division of Allergy and Clinical Immunology
Department of Medicine
National Jewish Health
C - Abbott, AstraZeneca, Boehringer-Ingelheim, Dey, L.P., Dynavax Technologies, Dyson, Genentech, GlaxoSmithKline, Johnson & Johnson, MediciNova, Novartis, Schering-Plough, Sepracor, Teva
I - Altana, AstraZeneca, Boehringer-Ingelheim, Ception, Genentech, Novartis, Schering-Plough, Sepracor, Wyeth
SP - AstraZeneca, GlaxoSmithKline

This activity is supported by an educational grant from Cephalon^®.